About Riverain Technologies

Shaping the Future of Diagnostic Excellence

For over 20 years, the Riverain has been a relentless innovator that empowers healthcare providers by streamlining diagnostic processes, elevating detection accuracy, and improving the outcomes of patients with cardiothoracic diagnoses. Riverain's ClearRead solutions significantly improve a clinician's ability to accurately and efficiently detect disease in thoracic (chest) CT and XR images and more successfully address the challenges of early detection of lung disease.

Leadership

Meet the leaders of Riverain, united on their mission to revolutionize radiology.

Learn More

Technology

Riverain's deep learning AI technology is FDA-cleared, clinically proven and tirelessly tested.

Learn More

Careers

Our dedicated Riverain team is passionate about making a real difference in people's lives.

Learn More

Revolutionizing Thoracic Imaging

Riverain Technologies led early advances in AI-driven medical imaging and continues to propel that technology to even greater heights.

First FDA Approval for Chest X-Ray CAD

Unique Suppression Patent

First FDA Approval for Concurrent Reading

First Lung Cancer Screening CAD Solution with Universal PACS Interoperability

Compatibility and Validation with Every Major AI Platform

Meet Our Clinical Advisors

Jared Christensen, MD, MBA

Dr. Jared Christensen is vice chair of strategy of the Duke University Department of Radiology and director of the Duke Lung Cancer Screening Program. He currently serves as chair of the American College of Radiology Lung-RADS Committee. Dr. Christensen's professional interests in AI focus on finding solutions that decrease variability, increase efficiency, and improve patient outcomes.

Jonathan Chung, MD

Dr. Jonathan Chung, Divisional Chief of Cardiothoracic Imaging, University of California San Diego Medical Center, specializes in cardiopulmonary imaging. He analyzes and interprets chest radiographs and CT scans for thoracic diseases. He also has expertise in interstitial lung disease, occupational lung disease, nontuberculous mycobacterial popularity, and diseases of the large and small airways. He has authored over 190 peer-reviewed articles that have been published in scientific journals, co-authored numerous book chapters and seven books that focus on chest diagnostics.

Charles White, MD

Dr. Charles White has been on the Riverain advisory board since 2013, and is Professor of Radiology and Medicine at the University of Maryland Medical Center. Dr. White has a special interest in the diagnosis and staging of lung cancer and cardiac CT imaging. Dr. White was named one of Baltimore Magazine's 2010 "Top Docs" for General Diagnostic Radiology.

Our Mission

To eliminate delayed cardio-thoracic disease diagnoses.

Our Vision

To be recognized as a transformative leader in the thoracic sciences.

Join the Riverain team

Riverain is using the latest advancements in technology to change the world of radiology and save lives. If you're a problem-solver interested in a rewarding and challenging career that is making a difference, we'd love to hear from you.

Riverain Careers